ABEONA THERAPEUTICS INC. Current Liabilities
ABEONA THERAPEUTICS INC. (ABEO) had Current Liabilities of $24.81 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $24.81M.
- 2026-03-31: Liabilities, Current $31.05M.
- 2025-12-31: Liabilities, Current $29.57M.
- 2025-09-30: Liabilities, Current $22.18M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $24.81M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $31.05M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $29.57M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $22.18M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $34.52M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $17.98M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $16.59M 10-K · filed 2026-03-17 |
| 2024-09-30 | $18.42M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $16.84M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $11.89M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $13.42M 10-K · filed 2025-03-20 |
| 2023-09-30 | $8.41M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $9.44M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $7.42M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.78M 10-K · filed 2024-03-18 |
| 2022-09-30 | $12.60M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $13.69M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $12.34M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $16.62M 10-K · filed 2023-03-29 |
| 2021-09-30 | $26.47M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $41.87M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $40.84M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $41.96M 10-K · filed 2022-03-31 |
| 2020-09-30 | $38.74M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $37.56M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $36.61M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $38.70M 10-K · filed 2021-03-24 |
| 2019-09-30 | $20.24M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $25.54M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $21.42M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $20.35M 10-K · filed 2020-03-16 |
| 2018-09-30 | $10.33M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $5.78M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.45M 10-Q · filed 2018-05-10 |
| 2018-01-02 | $2.61M 10-Q · filed 2018-11-09 |
| 2018-01-01 | $2.39M 10-K · filed 2019-03-18 |
| 2017-12-31 | $5.61M 10-K · filed 2019-03-18 |
| 2017-09-30 | $2.64M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $4.22M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $6.07M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $8.30M 10-K · filed 2018-03-16 |
| 2016-09-30 | $6.51M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $8.71M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $7.64M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $1.48M 10-K · filed 2017-03-30 |
| 2015-09-30 | $1.57M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $1.92M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $1.24M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $2.90M 10-K · filed 2016-03-30 |
| 2014-09-30 | $12.62M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $11.17M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $10.04M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $8.96M 10-K · filed 2015-03-31 |
| 2013-09-30 | $8.01M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $7.77M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $7.75M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $6.63M 10-K · filed 2014-03-26 |
| 2012-09-30 | $8.99M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $14.05M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $12.90M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $12.19M 10-K · filed 2013-03-20 |
| 2011-09-30 | $14.27M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $12.87M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $14.26M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |